Tarsus Pharmaceuticals Inc. (TARS) Social Stream
TARSUS PHARMACEUTICALS INC (TARS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering TARSUS PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 5 | $68 | $45 | $57.6 | $19.61 | 193.73% |
| 2021-11-23 | 6 | $68 | $45 | $57.166 | $19.61 | 191.51% |
| 2022-03-15 | 7 | $68 | $40 | $54.714 | $19.61 | 179.01% |
| 2022-03-17 | 7 | $69 | $40 | $54.857 | $19.61 | 179.74% |
| 2022-04-18 | 7 | $69 | $40 | $53.714 | $19.61 | 173.91% |
| 2022-05-03 | 7 | $69 | $39 | $55.142 | $19.61 | 181.19% |
| 2022-05-10 | 7 | $69 | $39 | $56.833 | $19.61 | 189.82% |
| 2022-07-09 | 7 | $66 | $40 | $54.714 | $19.61 | 179.01% |
| 2022-08-12 | 8 | $66 | $40 | $52.875 | $19.61 | 169.63% |
| 2022-09-17 | 8 | $66 | $40 | $53 | $19.61 | 170.27% |
| 2022-11-10 | 7 | $66 | $40 | $50.375 | $19.61 | 156.88% |
| 2023-02-08 | 7 | $66 | $40 | $49.333 | $19.61 | 151.57% |
| 2023-03-15 | 7 | $66 | $40 | $48.714 | $19.61 | 148.41% |
| 2023-05-10 | 7 | $65 | $40 | $48.428 | $19.61 | 146.96% |
| 2023-06-15 | 8 | $65 | $40 | $48.428 | $19.61 | 146.96% |
| 2023-06-20 | 8 | $70 | $40 | $48.375 | $19.61 | 146.69% |
| 2023-06-26 | 8 | $70 | $40 | $48.875 | $19.61 | 149.24% |
| 2023-07-17 | 9 | $70 | $40 | $48.875 | $19.61 | 149.24% |
| 2023-07-25 | 9 | $70 | $40 | $48.333 | $19.61 | 146.47% |
| 2023-07-26 | 8 | $70 | $42 | $54.875 | $19.61 | 179.83% |
| 2023-08-02 | 9 | $70 | $42 | $54.875 | $19.61 | 179.83% |
| 2023-08-11 | 7 | $70 | $30 | $51.285 | $19.61 | 161.52% |
| 2023-08-14 | 7 | $60 | $30 | $46.571 | $19.61 | 137.49% |
| 2023-10-26 | 7 | $60 | $30 | $47.571 | $19.61 | 142.59% |
| 2023-11-13 | 7 | $60 | $30 | $48.142 | $19.61 | 145.5% |
| 2023-11-20 | 9 | $60 | $19 | $44.5 | $19.61 | 126.93% |
| 2023-12-26 | 9 | $60.001 | $19 | $44.5 | $19.61 | 126.93% |
The Trend in the Analyst Price Target
TARS's average price target has moved up $4.7 over the prior 38 months.
Over the past 48 weeks, TARS's average upside potential has been 194.18%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 7 | 66 | 40 | 48.714 | 15.94 | 205.61% |
| 2023-03-24 | 7 | 65 | 40 | 48.428 | 11.92 | 306.28% |
| 2023-08-11 | 7 | 70 | 30 | 48.000 | 16.82 | 185.37% |
| 2023-11-13 | 9 | 60 | 30 | 47.000 | 17.17 | 173.73% |
| 2023-11-20 | 9 | 60 | 19 | 44.500 | 17.50 | 154.29% |
TARS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.22 | 8 | 0 | 1 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 13 months, TARS's average broker recommendation rating worsened by 0.22.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how TARSUS PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 3577.86% of that group.
- TARS has a lower variance in analysts' estimates than -2657.75% of all US stocks.
- In terms of how TARSUS PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 3831.14% of that group.
- TARSUS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 3521.09% of stocks in the small market cap category.
In the Pharmaceutical Products industry, SABS, MOLN, and SOPH are the three stocks most similar to TARSUS PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is TARS a Buy, Hold or Sell? See the POWR Ratings now!